Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 7, 2014; 20(45): 17132-17140
Published online Dec 7, 2014. doi: 10.3748/wjg.v20.i45.17132
Published online Dec 7, 2014. doi: 10.3748/wjg.v20.i45.17132
Table 3 Preoperative risk factors for recurrence n (%)
| Variables | Non recurrence(n = 169) | Recurrence(n = 129) | P value | Multivariate | |
| Relative risk | P value | ||||
| Age (yr) | 56.4 ± 9.6 | 56.2 ± 9.9 | 0.717 | ||
| Gender (male) | 123 (72.8) | 109 (84.5) | 0.026 | 2.192 (1.060–4.532) | 0.034 |
| Cause of HCC (HBV:HCV:Alcohol:Others) | 116:11:8:34 | 97:7:8:17 | 0.402 | ||
| PLT (× 103/μL) | 155.07 ± 80.10 | 149.53 ± 61.57 | 0.500 | ||
| Bilirubin (mg/dL) | 1.38 ± 7.88 | 0.90 ± 0.97 | 0.491 | ||
| ICG | 12.54 ± 16.83 | 10.43 ± 8.68 | 0.271 | ||
| CTP scores | 5.37 ± 0.72 | 5.44 ± 0.71 | 0.409 | ||
| MELD scores | 6.26 ± 3.03 | 6.48 ± 2.79 | 0.521 | ||
| AFP (ng/mL) | 868.10 ± 4358.4 | 2212.3 ± 14588.5 | 0.264 | ||
| > 100 (n = 101) | 48 (28.4) | 53 (41.1) | 0.004 | 1.888 (1.094–3.588) | 0.050 |
| PIVKA II (mAU/mL) | 327.4 ± 886.0 | 795.1 ± 2040.9 | 0.048 | ||
| > 100 (n = 55) | 32 (18.9) | 23 (17.8) | 0.466 | ||
| Tumor size (cm) | 3.84 ± 2.66 | 5.28 ± 3.46 | < 0.001 | ||
| > 5 (n = 72) | 27 (16.0) | 45 (34.9) | < 0.001 | 1.516 (0.797–2.882) | 0.204 |
| Tumor number | 1.18 ± 0.57 | 1.39 ± 1.10 | 0.046 | ||
| Multiple (n = 40) | 19 (11.2) | 21 (16.2) | 0.124 | ||
| SUVs on PET CT | 3.84 ± 1.80 | 5.94 ± 4.20 | 0.001 | ||
| > 3.5 (n = 47) | 22 (13.0) | 25 (19.4) | 0.005 | 2.025 (1.046–3.921) | 0.036 |
| RER (n = 100) | 0.75 ± 0.16 | 0.72 ± 0.12 | 0.295 | ||
| < 0.6 (n = 11) | 4 (2.4) | 7 (5.4) | 0.011 | ||
- Citation: Han JH, Kim DG, Na GH, Kim EY, Lee SH, Hong TH, You YK. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma. World J Gastroenterol 2014; 20(45): 17132-17140
- URL: https://www.wjgnet.com/1007-9327/full/v20/i45/17132.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i45.17132